Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 24

1.

An Iron Oxide Nanocarrier Loaded with a Pt(IV) Prodrug and Immunostimulatory dsRNA for Combining Complementary Cancer Killing Effects.

Hernández-Gil J, Cobaleda-Siles M, Zabaleta A, Salassa L, Calvo J, Mareque-Rivas JC.

Adv Healthc Mater. 2015 Apr 2. doi: 10.1002/adhm.201500080. [Epub ahead of print]

PMID:
25846677
2.

Simulation climate change impact on runoff and sediment yield in a small watershed in the basque country, northern Spain.

Zabaleta A, Meaurio M, Ruiz E, Antigüedad I.

J Environ Qual. 2014 Jan;43(1):235-45. doi: 10.2134/jeq2012.0209.

PMID:
25602556
3.

Toward defining the anatomo-proteomic puzzle of the human brain: An integrative analysis.

Fernandez-Irigoyen J, Labarga A, Zabaleta A, de Morentin XM, Perez-Valderrama E, Zelaya MV, Santamaria E.

Proteomics Clin Appl. 2014 Nov 24. doi: 10.1002/prca.201400127. [Epub ahead of print]

PMID:
25418211
4.

Helper cell-independent antitumor activity of potent CD8+ T cell epitope peptide vaccines is dependent upon CD40L.

Llopiz D, Huarte E, Ruiz M, Bezunartea J, Belsúe V, Zabaleta A, Lasarte JJ, Prieto J, Borrás-Cuesta F, Sarobe P.

Oncoimmunology. 2013 Dec 1;2(12):e27009. Epub 2013 Dec 5.

5.

Enhanced T cell responses against hepatitis C virus by ex vivo targeting of adenoviral particles to dendritic cells.

Echeverria I, Pereboev A, Silva L, Zabaleta A, Riezu-Boj JI, Bes M, Cubero M, Borras-Cuesta F, Lasarte JJ, Esteban JI, Prieto J, Sarobe P.

Hepatology. 2011 Jul;54(1):28-37. doi: 10.1002/hep.24325. Epub 2011 May 14.

PMID:
21452282
6.

Monocyte-derived dendritic cells from HCV-infected patients transduced with an adenovirus expressing NS3 are functional when stimulated with the TLR3 ligand poly(I:C).

Echeverría I, Zabaleta A, Silva L, Díaz-Valdés N, Riezu-Boj JI, Lasarte JJ, Borrás-Cuesta F, Civeira MP, Prieto J, Sarobe P.

J Viral Hepat. 2008 Nov;15(11):782-9. doi: 10.1111/j.1365-2893.2008.01020.x. Epub 2008 Jul 10.

PMID:
18637068
7.

Vaccination against hepatitis C virus with dendritic cells transduced with an adenovirus encoding NS3 protein.

Zabaleta A, Llopiz D, Arribillaga L, Silva L, Riezu-Boj JI, Lasarte JJ, Borrás-Cuesta F, Prieto J, Sarobe P.

Mol Ther. 2008 Jan;16(1):210-7. Epub 2007 Oct 9.

PMID:
17923840
8.

Combined immunization with adjuvant molecules poly(I:C) and anti-CD40 plus a tumor antigen has potent prophylactic and therapeutic antitumor effects.

Llopiz D, Dotor J, Zabaleta A, Lasarte JJ, Prieto J, Borrás-Cuesta F, Sarobe P.

Cancer Immunol Immunother. 2008 Jan;57(1):19-29. Epub 2007 Jun 13.

PMID:
17564702
9.

Structured group-based education for type 2 diabetes in primary care.

Zabaleta AM, Forbes A.

Br J Community Nurs. 2007 Apr;12(4):158-62. Review.

PMID:
17505331
10.

[Health related quality of life in patients with diabetes mellitus type 2].

Hervás A, Zabaleta A, De Miguel G, Beldarráin O, Díez J.

An Sist Sanit Navar. 2007 Jan-Apr;30(1):45-52. Spanish.

11.

Induction of potent and long-lasting CD4 and CD8 T-cell responses against hepatitis C virus by immunization with viral antigens plus poly(I:C) and anti-CD40.

Zabaleta A, Arribillaga L, Llopiz D, Dotor J, Lasarte JJ, Prieto J, Borrás-Cuesta F, Esteban JI, Quer J, Vayreda F, Sarobe P.

Antiviral Res. 2007 Apr;74(1):25-35. Epub 2007 Jan 22.

PMID:
17275104
12.

Engineered promiscuous T helper peptides for the induction of immune responses.

Ruiz M, Llopiz D, Zabaleta A, Lasarte JJ, Borrás-Cuesta F, Sarobe P.

Mol Immunol. 2007 Mar;44(9):2205-12. Epub 2006 Dec 8.

PMID:
17157914
13.

[Impact of common reasons for consultation on the feeling of vitality and the physical performance of the over-65s].

Sánchez Lasheras T, Goñi Ruiz N, Serrano-Martínez M, Buil P, Zabaleta A, de Miguel G, Beldarrain O, Díez Espino J.

Aten Primaria. 2005 Mar 31;35(5):246-52. Spanish.

PMID:
15802112
14.

Mutants of plasminogen activator inhibitor-1 designed to inhibit neutrophil elastase and cathepsin G are more effective in vivo than their endogenous inhibitors.

Stefansson S, Yepes M, Gorlatova N, Day DE, Moore EG, Zabaleta A, McMahon GA, Lawrence DA.

J Biol Chem. 2004 Jul 16;279(29):29981-7. Epub 2004 May 6.

15.

Hepatitis C virus structural proteins impair dendritic cell maturation and inhibit in vivo induction of cellular immune responses.

Sarobe P, Lasarte JJ, Zabaleta A, Arribillaga L, Arina A, Melero I, Borrás-Cuesta F, Prieto J.

J Virol. 2003 Oct;77(20):10862-71.

16.

Modification of ocular defects in mouse developmental glaucoma models by tyrosinase.

Libby RT, Smith RS, Savinova OV, Zabaleta A, Martin JE, Gonzalez FJ, John SW.

Science. 2003 Mar 7;299(5612):1578-81.

17.

Environmental transformation of the Bilbao estuary, N. Spain: microfaunal and geochemical proxies in the recent sedimentary record.

Cearreta A, Irabien MJ, Leorri E, Yusta I, Quintanilla A, Zabaleta A.

Mar Pollut Bull. 2002 Jun;44(6):487-503.

PMID:
12146832
18.

Mutations in genes encoding melanosomal proteins cause pigmentary glaucoma in DBA/2J mice.

Anderson MG, Smith RS, Hawes NL, Zabaleta A, Chang B, Wiggs JL, John SW.

Nat Genet. 2002 Jan;30(1):81-5. Epub 2001 Dec 17.

PMID:
11743578
19.

Haploinsufficient Bmp4 ocular phenotypes include anterior segment dysgenesis with elevated intraocular pressure.

Chang B, Smith RS, Peters M, Savinova OV, Hawes NL, Zabaleta A, Nusinowitz S, Martin JE, Davisson ML, Cepko CL, Hogan BL, John SW.

BMC Genet. 2001;2:18. Epub 2001 Nov 6.

20.

The mouse anterior chamber angle and trabecular meshwork develop without cell death.

Smith RS, Zabaleta A, Savinova OV, John SW.

BMC Dev Biol. 2001;1:3. Epub 2001 Feb 14.

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Loading ...
Write to the Help Desk